Cadrenal Therapeutics, Inc.

CVKD·NASDAQ·$5.19Share Price as of 11/2·$15MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/31/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/11/25

Disclosures

8-KCurrent report10/07/26 8-KChange in Directors or Officers; Shareholder Vote Results09/29/26 8-KRegulation FD Disclosure; Other Events08/31/26 8-KResults of Operations08/13/26 8-KRegulation FD Disclosure; Other Events07/21/26

Prospectuses and Registrations

S-8Registration of securities for employees10/08/26 S-8Registration of securities for employees09/03/26 424B3Prospectus07/20/26 S-3Shelf registration07/13/26 424B3Prospectus04/29/26

Proxies

DEF 14ADefinitive proxy08/03/26 DEFA14AAdditional proxy materials08/03/26 PRE 14APreliminary proxy07/23/26 DEF 14ADefinitive proxy07/31/25 DEFA14AAdditional proxy materials07/31/25

Ownership

Form 4Insider transaction10/13/26 Form 4Insider transaction10/13/26 Form 4Insider transaction10/13/26 Form 4Insider transaction10/13/26 Form 4Insider transaction10/13/26

Other

ARSAnnual report to shareholders08/03/26 EFFECTRequest for effectiveness07/20/26 DD07/15/26 EFFECTRequest for effectiveness04/29/26 CORRESPCorrespondence with the SEC04/27/26